Excess granulation tissue development during treatment with cyclosporin.
Wakelin
S H
SH
Emmerson
R W
RW
D000293:Adolescent; D016572:Cyclosporine / Q000009:adverse effects*; D006097:Granulation Tissue / Q000473:pathology*; D006801:Humans; D006965:Hyperplasia / Q000139:chemically induced; D008297:Male; D011565:Psoriasis / Q000473:pathology*
D016572:Cyclosporine